UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025802
Receipt number R000029672
Scientific Title Clinical trial of controlled-release function by gelling agent in food.
Date of disclosure of the study information 2017/01/23
Last modified on 2017/07/25 18:59:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial of controlled-release function by gelling agent in food.

Acronym

Clinical trial of controlled-release function by gelling agent in food.

Scientific Title

Clinical trial of controlled-release function by gelling agent in food.

Scientific Title:Acronym

Clinical trial of controlled-release function by gelling agent in food.

Region

Japan


Condition

Condition

Healthy volunteer

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the conrolled-release function bygelling agent in food.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

AUC,Cmax and Tmax of blood curcumin and blood tetrahydrocurcumin.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Curcumin jelly 1
Single ingestion 15 g

Interventions/Control_2

Curcumin jelly 2
Single ingestion 15 g

Interventions/Control_3

Curcumin jelly 3
Single ingestion 15 g

Interventions/Control_4

Curcumin drink
Single ingestion 15 g

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

1)The healthy men and women less than 50 years old more than 20 years old.
2)BMI >=18.5 kg/m*m and <25 kg/m*m.

Key exclusion criteria

1) Subjects who are difficulty of over time the blood collection.
2) Subjects who are taking medicine or being treated by a doctor.
3) Subjects who previous or present serious disease such hemopathy, circulatory, breathing, liver, kidney or digestive system disease.
4) Subjects who are participating or planning to participate in other clinical study.
5) Subjects who cannot stop taking healthy food from one week before to the end of the test period.
6) Subjects who are taking healthy food containing turmeric.
7) Subjects who cannot stop taking of turmeric food from 3 days before to the end of test day.
8) Subjects who may cause allergic to turmeric.
9) Women who are pregnant or breast-feeding.
10) Subjects who are judged as unsuitable for this study by study director.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sayuri Matsuoka

Organization

FANCL Corporation

Division name

Research Institute

Zip code


Address

Kamishinano 12-13, Totsuka-ku, Yokohama, Kanagawa,244-0806

TEL

045-820-3522

Email

matsuoka@fancl.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Mizuki Watanabe

Organization

FANCL Corporation

Division name

Research Institute

Zip code


Address

Kamishinano 12-13, Totsuka-ku, Yokohama, Kanagawa,244-0806

TEL

045-820-3659

Homepage URL


Email

mizuki1604@fancl.co.jp


Sponsor or person

Institute

FANCL

Institute

Department

Personal name



Funding Source

Organization

FANCL Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ファンケル総合研究所/FANCL Reseach Instite


Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 01 Month 19 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 25 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 23 Day

Last modified on

2017 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029672


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name